Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics
- PMID: 20305752
- PMCID: PMC2842101
- DOI: 10.3389/fnbeh.2010.00008
Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics
Abstract
Recent human studies suggest a role for altered oligodendrocytes in the pathophysiology of schizophrenia. Our recent animal study has reported some schizophrenia-like behaviors in mice exposed to cuprizone (Xu et al., 2009), a copper chelator that has been shown to selectively damage the white matter. This study was to explore mechanisms underlying the behavioral changes in cuprizone-exposed mice and to examine effects of the antipsychotics haloperidol, clozapine and quetiapine on the changes in the mice. Mice given cuprizone for 14 days showed a deficit in the prepulse inhibition of acoustic startle response and higher dopamine in the prefrontal cortex (PFC), which changes were not seen in mice given cuprizone plus antipsychotics. Mice given cuprizone for 21 days showed lower spontaneous alternations in Y-maze, which was not seen in mice treated with cuprizone plus the antipsychotics. Mice given cuprizone for 28 days displayed less social interactions, which was not seen in mice given cuprizone plus clozapine/quetiapine, but was seen in mice given cuprizone plus haloperidol. Mice given cuprizone for 42 days showed myelin sheath loss and lower myelin basic protein in PFC, caudate putamen, and hippocampus. The white matter damage in PFC was attenuated in mice given cuprizone plus clozapine/haloperidol. But the white matter damage in caudate putamen and hippocampus was only attenuated by clozapine and quetiapine, not by haloperidol. These results help us to understand the behavioral changes and provide experimental evidence for the protective effects of antipsychotics on white matter damage in cuprizone-exposed mice.
Keywords: MBP; antipsychotics; behavior; mouse; oligodendrocytes; schizophrenia model.
Figures







Similar articles
-
Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs.Front Behav Neurosci. 2011 Jul 1;5:31. doi: 10.3389/fnbeh.2011.00031. eCollection 2011. Front Behav Neurosci. 2011. PMID: 21747763 Free PMC article.
-
Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801.Brain Res Bull. 2021 Sep;174:141-152. doi: 10.1016/j.brainresbull.2021.06.007. Epub 2021 Jun 11. Brain Res Bull. 2021. PMID: 34119597
-
Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia.Brain Res. 2009 May 13;1270:121-30. doi: 10.1016/j.brainres.2009.03.011. Epub 2009 Mar 21. Brain Res. 2009. PMID: 19306847
-
Novel pharmacological approaches to the treatment of schizophrenia.Dan Med Bull. 2000 Jun;47(3):151-67. Dan Med Bull. 2000. PMID: 10913983 Review.
-
The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.Brain Pathol. 2001 Jan;11(1):107-16. doi: 10.1111/j.1750-3639.2001.tb00385.x. Brain Pathol. 2001. PMID: 11145196 Free PMC article. Review.
Cited by
-
Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.Schizophr Res. 2012 Sep;140(1-3):122-8. doi: 10.1016/j.schres.2012.06.036. Epub 2012 Jul 17. Schizophr Res. 2012. PMID: 22809684 Free PMC article. Clinical Trial.
-
The Cuprizone Model: Dos and Do Nots.Cells. 2020 Mar 31;9(4):843. doi: 10.3390/cells9040843. Cells. 2020. PMID: 32244377 Free PMC article. Review.
-
Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia.Int J Mol Sci. 2023 Apr 22;24(9):7680. doi: 10.3390/ijms24097680. Int J Mol Sci. 2023. PMID: 37175387 Free PMC article. Review.
-
Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination.Neurosci Bull. 2015 Oct;31(5):617-25. doi: 10.1007/s12264-015-1555-3. Epub 2015 Aug 6. Neurosci Bull. 2015. PMID: 26253956 Free PMC article.
-
Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination.Front Cell Neurosci. 2018 Sep 12;12:297. doi: 10.3389/fncel.2018.00297. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30258354 Free PMC article. Review.
References
-
- Abi-Dargham A., Rodenhiser J., Printz D., Zea-Ponce Y., Gil R., Kegeles L. S., Weiss R., Cooper T. B., Mann J. J., Van Heertum R. L., Gorman J. M., Laruelle M. (2000). Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 97, 8104–810910.1073/pnas.97.14.8104 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous